Company records / parallel.bio
Parallel Bio
Parallel Bio (parallel.bio): 2 changes recorded in its website history since December 2022. Homepage last checked 6 November 2026.
Recorded changes
- HeadlineBetween and
Unlocking the human body’s own power to cure disease.
Delivering safe, effective therapies without a clinical trial
- HeadlineBetween and
Next generation tools to rapidly discover immunotherapies.
Unlocking the human body’s own power to cure disease.
First recorded website
Observed 21 December 2022
How it described itself
Next generation tools to rapidly discover immunotherapies.
Homepage
- Funding statements on the website
- Stay Up To Date Parallel Bio Secures $4.3 Million Seed Round to Accelerate Drug Discovery through Human Immune System in a Dish ParallelBio is one of TechCrunch’s favorite startups from YC Summer 2021 demo day.
How it describes itself
Delivering safe, effective therapies without a clinical trial
Inspect 2 captures in this group
- ·
Delivering safe, effective therapies without a clinical trial
archived page - ·
Delivering safe, effective therapies without a clinical trial
archived page
- ·
Unlocking the human body’s own power to cure disease.
Next generation tools to rapidly discover immunotherapies.
Inspect 2 captures in this group
- ·
Next generation tools to rapidly discover immunotherapies.
archived page - ·
Next generation tools to rapidly discover immunotherapies.
archived page
- ·
Cite this record
StartupHistory, “Parallel Bio” company record, https://startuphistory.org/c/parallel.bio